Modulating the serotonin system in the treatment of major depressive disorder
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Learning Objective: Discuss the theory of modulation of receptor activity or the blockade of the reuptake of multiple neurotransmitter systems for the future treatment of MDD. Major depressive disorder (MDD) is a serious and often crippling psychiatric illness with a high risk of relapse and treatment resistance. In this article, we discuss the role of the serotonergic system in MDD including our current understanding of how various serotonin (5HT) receptors modulate monoamine neurotransmission and behavior. We also discuss how pharmacologic interventions, including novel and existing antidepressants and atypical antipsychotics, may be utilized to adjust serotonergic neurotransmission and provide more effective treatments for patients with MDD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The State of US Health, 1990-2010: Burden of Diseases, Injuries, and Risk Factors
Murray, C. J. L. (2013) · JAMA · doi:10.1001/jama.2013.13805 · Cited by 2,438
Circadian misalignment and health
Baron, K. G., & Reid, K. J. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2014.911149 · Cited by 645 · cited 7×
“We also discuss how pharmacologic interventions, including novel and existing antidepressants and atypical antipsychotics, may be utilized to adjust serotonergic neurotransmission and provide more effective treatments for patients with MDD. Received 2 October 2014; Accepted 11 October 2014 Key words: atypical antipsyc…”
BackgroundInfluentialStahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications
Stahl, S. M. (2021) · doi:10.1017/9781108975292 · Cited by 480
Self-citationSerotonin receptors involved in antidepressant effects
Artigas, F. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.09.006 · Cited by 311
The role of serotonin receptor subtypes in treating depression: a review of animal studies
Carr, G. V., & Lucki, I. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2097-z · Cited by 260
The serotonergic system in mood disorders and suicidal behaviour
Mann, J. J. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0537 · Cited by 235 · cited 2×
“The reason for this may be due to the inhibitory effects of 5HT autoreceptor stimulation.(4,5) The initial increase in a monoamine (eg, 5HT) following treatment with an antidepressant (eg, an SSRI) results in activation of 5HT1A, 5HT1B, and 5HT1D autoreceptors, which in turn causes a decrease in 5HT output (Figure 9).”
BackgroundLinks between circadian rhythms and psychiatric disease
Karatsoreos, I. N. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00162 · Cited by 146
Bulloch, A., Williams, J., Lavorato, D., & Patten, S. (2014) · Depression and Anxiety · doi:10.1002/da.22173 · Cited by 45 · cited 1×
“Many patients with MDD do not respond to currently available treatments and suffer through recurring depressive episodes.(2) The monoamine hypothesis of depression, which posits that depression results from a deficiency in serotonin (5HT), norepinephrine (NE), and dopamine (DA), has been the mainstay of antidepressant…”
Background
Cited by
Jenkins, T., Nguyen, J., Polglaze, K., & Bertrand, P. (2016) · Nutrients · doi:10.3390/nu8010056 · Cited by 904
“The mechanism of these medications is believed to be in part by increasing synaptic levels of monoamines, mainly serotonin and noradrenaline and subsequent activation of serotoninergic and noradrenergic postsynaptic and autoreceptors [17].”
BackgroundScope and limitations of iodothyronine deiodinases in hypothyroidism
Gereben, B., McAninch, E. A., Ribeiro, M. O., & Bianco, A. C. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.155 · Cited by 146
Abbas, A., Sauder, C., Yadav, V., Koesmahargyo, V., Aghjayan, A., Marecki, S., Evans, M., & Galatzer-Levy, I. R. (2021) · Frontiers in Digital Health · doi:10.3389/fdgth.2021.610006 · Cited by 49
Galatzer-Levy, I., Abbas, A., Ries, A., Homan, S., Sels, L., Koesmahargyo, V., Yadav, V., Colla, M., Scheerer, H., Vetter, S., et al. (2021) · Journal of Medical Internet Research · doi:10.2196/25199 · Cited by 23
The sigma–1 receptor: a mechanistically–informed therapeutic target for antidepressants
Xiao, N., Yin, L., Teopiz, K. M., Kwan, A. T. H., Le, G. H., Wong, S., Valentino, K., Choi, H., Rosenblat, J. D., Ho, R., et al. (2025) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2025.2500424 · Cited by 6
“Consensus exists that multiple neurobiological systems mediate antidepressant actions directly or indirectly [2].”
Metadata
- Authors
- Morrissette, D. A., & Stahl, S. M.
- Venue
- CNS Spectrums
- Publisher
- Cambridge University Press (CUP)
- Published
- 2014-12
- Volume
- 19
- Issue
- S1
- Pages
- 54-68
- ISSN
- 1092-8529 (ISSN-L)
- 2165-6509
- OpenAlex
- W2124105769
- Cited by
- 64
- References
- 8
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modulating the serotonin system in the treatment of major depressive disorder. https://app.cochat.ai/papers/10.1017/s1092852914000613
- The paper
- Morrissette, D. A., & Stahl, S. M. (2014). Modulating the serotonin system in the treatment of major depressive disorder. CNS Spectrums. https://doi.org/10.1017/s1092852914000613
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.